224 related articles for article (PubMed ID: 31668346)
1. Risk of Atrial Fibrillation in Relation to the Time Course of Type 2 Diabetes Mellitus and Fasting Blood Glucose.
Yang S; Choi EK; Han KD; Kwon S; Lee SY; Park J; Choi YJ; Lee HJ; Moon I; Lee E; Lee SR; Cha MJ; Lim WH; Oh S
Am J Cardiol; 2019 Dec; 124(12):1881-1888. PubMed ID: 31668346
[TBL] [Abstract][Full Text] [Related]
2. Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting.
Fu SN; Luk W; Wong CK; Cheung KL
J Diabetes; 2014 Sep; 6(5):438-46. PubMed ID: 24393475
[TBL] [Abstract][Full Text] [Related]
3. Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
Latini R; Staszewsky L; Sun JL; Bethel MA; Disertori M; Haffner SM; Holman RR; Chang F; Giles TD; Maggioni AP; Rutten GE; Standl E; Thomas L; Tognoni G; Califf RM; McMurray JJ
Am Heart J; 2013 Nov; 166(5):935-40.e1. PubMed ID: 24176451
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan.
Chang CY; Yeh YH; Chan YH; Liu JR; Chang SH; Lee HF; Wu LS; Yen KC; Kuo CT; See LC
Cardiovasc Diabetol; 2017 Dec; 16(1):159. PubMed ID: 29258504
[TBL] [Abstract][Full Text] [Related]
5. The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study.
Kim YG; Han KD; Choi JI; Boo KY; Kim DY; Oh SK; Lee KN; Shim J; Kim JS; Kim YH
Cardiovasc Diabetol; 2019 Oct; 18(1):128. PubMed ID: 31575379
[TBL] [Abstract][Full Text] [Related]
6. High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study.
Lee HJ; Choi EK; Han KD; Kim DH; Lee E; Lee SR; Oh S; Lip GYH
Cardiovasc Diabetol; 2020 Jun; 19(1):78. PubMed ID: 32534567
[TBL] [Abstract][Full Text] [Related]
7. Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: A nationwide cohort study in South Korea.
Kim S; Park SY; Kim B; Min C; Cho W; Yon DK; Kim JY; Han KD; Rhee EJ; Lee WY; Rhee SY
Diabetes Res Clin Pract; 2023 Apr; 198():110626. PubMed ID: 36933806
[TBL] [Abstract][Full Text] [Related]
8. The Association of Resting Heart Rate with the Presence of Diabetes in Korean Adults: The 2010-2013 Korea National Health and Nutrition Examination Survey.
Hong JW; Noh JH; Kim DJ
PLoS One; 2016; 11(12):e0168527. PubMed ID: 27992613
[TBL] [Abstract][Full Text] [Related]
9. Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study.
Ahn HJ; Han KD; Choi EK; Jung JH; Kwon S; Lee SR; Oh S; Lip GYH
Cardiovasc Diabetol; 2021 Jan; 20(1):20. PubMed ID: 33468142
[TBL] [Abstract][Full Text] [Related]
10. Risk of optic neuritis in type 2 diabetes mellitus: A nationwide cohort study.
Lee GI; Han K; Park KA; Oh SY
J Neurol Sci; 2023 Jul; 450():120673. PubMed ID: 37201268
[TBL] [Abstract][Full Text] [Related]
11. Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart study.
Fu L; Deng H; Lin WD; He SF; Liu FZ; Liu Y; Zhan XZ; Fang XH; Liao HT; Wei W; Liao ZL; Tang LH; Fu ZY; Zheng MR; Wu SL; Xue YM
BMC Cardiovasc Disord; 2019 Nov; 19(1):270. PubMed ID: 31779588
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
Papazoglou AS; Kartas A; Samaras A; Vouloagkas I; Vrana E; Moysidis DV; Akrivos E; Kotzampasis G; Baroutidou A; Papanastasiou A; Liampas E; Botis M; Karagiannidis E; Stalikas N; Karvounis H; Tzikas A; Giannakoulas G
Cardiovasc Diabetol; 2021 Feb; 20(1):40. PubMed ID: 33573666
[TBL] [Abstract][Full Text] [Related]
13. Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea.
Lee SS; Ae Kong K; Kim D; Lim YM; Yang PS; Yi JE; Kim M; Kwon K; Bum Pyun W; Joung B; Park J
Eur Heart J; 2017 Sep; 38(34):2599-2607. PubMed ID: 28662568
[TBL] [Abstract][Full Text] [Related]
14. The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study.
Lee JH; Han K; Huh JH
Cardiovasc Diabetol; 2020 Apr; 19(1):44. PubMed ID: 32238157
[TBL] [Abstract][Full Text] [Related]
15. Associations of high-normal blood pressure and impaired fasting glucose with atrial fibrillation.
Kim J; Kim D; Jang E; Kim D; You SC; Yu HT; Lee MY; Lip G; Yang PS; Joung B
Heart; 2023 May; 109(12):929-935. PubMed ID: 36750354
[TBL] [Abstract][Full Text] [Related]
16. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
[TBL] [Abstract][Full Text] [Related]
17. Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus.
Hsu JC; Yang YY; Chuang SL; Yu CC; Lin LY
Cardiovasc Diabetol; 2021 Jul; 20(1):148. PubMed ID: 34301257
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice.
Tadic M; Cuspidi C
Arch Cardiovasc Dis; 2015 Apr; 108(4):269-76. PubMed ID: 25858534
[TBL] [Abstract][Full Text] [Related]
19. Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis.
Bisson A; Bodin A; Fauchier G; Herbert J; Angoulvant D; Ducluzeau PH; Lip GYH; Fauchier L
Cardiovasc Diabetol; 2021 Jan; 20(1):24. PubMed ID: 33482830
[TBL] [Abstract][Full Text] [Related]
20. Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study.
Seyed Ahmadi S; Svensson AM; Pivodic A; Rosengren A; Lind M
Cardiovasc Diabetol; 2020 Jan; 19(1):9. PubMed ID: 31954408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
